
Lonza Group Investor Relations Material
Latest events

H1 2025
Lonza Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lonza Group AG
Access all reports
Lonza Group AG offers contract development and manufacturing services to the pharmaceutical, biotechnology, and specialty ingredients markets. The company supports drug production across biologics, small molecules, and cell and gene therapy, along with nutrition and personal care ingredients. It operates manufacturing and research facilities globally. The company is headquartered in Basel, Switzerland, and its shares are listed on the SIX.
Key slides for Lonza Group AG


H2 2024
Lonza Group AG


H2 2024
Lonza Group AG
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
LONN
Country
🇨🇭 Switzerland